Real-time enrollment status for this duchenne muscular dystrophy clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:22 AM UTC
| NCT Number | NCT06817382 |
| Recruiting Status | Recruiting |
| Condition | Duchenne Muscular Dystrophy |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Insmed Gene Therapy LLC |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of August 28, 2026: Clinical trial NCT06817382 is currently recruiting participants. This phase1 study for duchenne muscular dystrophy is actively seeking new participants at 10 locations across the United States. The study is sponsored by Insmed Gene Therapy LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06817382 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06817382 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.